+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
HLA Typing Market - Global Forecast 2026-2032- Product Image
HLA Typing Market - Global Forecast 2026-2032- Product Image
Sale

HLA Typing Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674346
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The HLA Typing Market is projected to reach USD 1.77 Billion in 2026. It is expected to continue growing at a CAGR of 6.38%, reaching USD 2.57 Billion by 2032.

HLA typing is a core precision-medicine capability used to characterize human leukocyte antigen genes that regulate immune recognition. The field is anchored by solid organ transplantation, hematopoietic stem cell transplantation, transfusion support, pharmacogenomics, disease-association research, vaccine studies, and emerging cell and gene therapy workflows.

Demand is supported by measurable clinical need: transplant programs rely on high-resolution HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, and HLA-DPB1 data to reduce graft rejection risk, improve donor selection, and support post-transplant monitoring. International donor registries coordinated through organizations such as the World Marrow Donor Association include tens of millions of volunteer donors and cord blood units, creating a durable requirement for standardized, interoperable HLA data.

The competitive landscape is shifting from low-to-intermediate resolution methods toward next-generation sequencing, automation, digital interpretation, and integrated laboratory information systems. As laboratories balance turnaround time, reimbursement pressure, sample complexity, and quality requirements, providers that combine accuracy, workflow efficiency, and regulatory-ready informatics are positioned to strengthen adoption.

Transformative Shifts Reshaping HLA Typing

The HLA typing landscape is being transformed by the move from serology and sequence-specific oligonucleotide or primer-based assays to sequencing-led, high-resolution typing. Next-generation sequencing enables broader locus coverage, improved ambiguity resolution, and scalable batch processing, which are increasingly important for transplant centers and donor registries managing genetically diverse populations.

A second shift is the expansion of HLA typing beyond transplant compatibility into immunology, autoimmune disease research, oncology, pharmacogenomics, infectious disease studies, and cell therapy manufacturing. Well-established HLA associations with drug hypersensitivity, including HLA-B*57:01 for abacavir and HLA-B*15:02 for carbamazepine-related severe cutaneous adverse reactions in specific ancestries, demonstrate the clinical value of HLA data outside transplantation.

The field is also being shaped by standardization and interoperability. Laboratories are aligning with accreditation requirements, proficiency testing, and reporting conventions from transplant and histocompatibility organizations, while health systems increasingly expect HLA results to integrate with electronic health records, donor registries, laboratory information systems, and clinical decision-support platforms.

Cumulative Impact of Artificial Intelligence on HLA Typing

Artificial intelligence is adding value across HLA typing workflows, particularly in sequence interpretation, allele calling, ambiguity reduction, quality-control flagging, and donor-recipient matching. Machine learning models can help prioritize likely alleles from complex sequencing data and support faster review by trained laboratory professionals.

AI is also advancing immunogenetics by improving HLA imputation from SNP-array or genomic datasets, modeling peptide-HLA binding, and supporting epitope-level assessment. These applications are relevant to transplant risk stratification, vaccine research, oncology neoantigen discovery, immune-mediated disease studies, and personalized immunotherapy development.

The cumulative impact is operational rather than fully autonomous: AI improves speed, consistency, and decision support, but clinical-grade HLA typing still requires validated assays, curated reference databases, quality systems, and expert oversight. Organizations that pair AI with transparent validation, audit trails, cybersecurity, and regulatory compliance will build stronger trust with clinicians, laboratories, and payers.

Key Regional Insights Across Global HLA Typing Demand

Asia-Pacific is becoming one of the most dynamic regions for HLA typing as China, India, Japan, South Korea, Australia, and ASEAN healthcare systems expand transplant capacity, oncology programs, and genomics infrastructure. Population diversity across the region creates a strong need for high-resolution allele databases that better represent local ancestries, improve donor matching, and support equitable access to precision immunogenetics.

North America remains highly advanced because of established transplant networks, mature donor registries, broad adoption of molecular diagnostics, and well-developed reimbursement pathways for clinically necessary testing. The United States anchors demand through transplant centers, histocompatibility laboratories, academic medical centers, and biopharma research, while Canada contributes through coordinated transplant systems and quality-focused laboratory standards.

Europe benefits from coordinated healthcare systems, cross-border donor collaboration, strong laboratory accreditation, and extensive clinical research infrastructure. Latin America is expanding through Brazil- and Mexico-led transplant activity, although access, reimbursement, and laboratory infrastructure vary across countries. The Middle East, supported by GCC investment in specialty care and national genomics initiatives, is strengthening transplant and molecular diagnostics capabilities, while Africa represents a long-term access opportunity as laboratory networks, donor registries, workforce training, and transplant programs mature.

Key Group Insights for HLA Typing Adoption

ASEAN markets are gaining importance as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines invest in molecular diagnostics, tertiary care, and genomics-enabled public health capabilities. The region’s genetic diversity increases the value of localized HLA datasets, high-resolution workflows, and scalable next-generation sequencing systems that can serve both transplant and research applications.

The GCC is prioritizing specialty healthcare, transplant services, precision medicine, and national genomics programs, creating demand for high-quality HLA typing systems, workforce training, and secure data management. The European Union benefits from regulatory harmonization, structured procurement frameworks, cross-border healthcare collaboration, and established donor registry and transplant networks that support standardized HLA reporting.

BRICS economies represent a major development corridor because China, India, Brazil, Russia, and South Africa combine large populations with expanding healthcare capacity and increasing genomics investment. G7 markets lead in clinical adoption, automation, accreditation maturity, and high-value research use cases, while NATO countries overlap with many advanced healthcare systems where resilience, secure data exchange, supply continuity, and trusted diagnostic infrastructure are strategic priorities.

Key Country Insights in HLA Typing

The United States leads HLA typing demand through high transplant activity, advanced histocompatibility laboratories, mature donor registry infrastructure, and strong biomedical research funding. Canada emphasizes quality-assured transplant networks and standardized laboratory practices, while Mexico and Brazil are expanding access to molecular diagnostics and transplant services across large, genetically diverse populations.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine established transplant programs with advanced laboratory infrastructure and active immunogenetics research. Germany and France are particularly influential in laboratory automation, accreditation-driven quality systems, and clinical research adoption, while the United Kingdom supports strong genomics integration and registry collaboration. Italy and Spain maintain important transplant and donor-matching capabilities, and Russia sustains demand through large-scale healthcare delivery and academic immunogenetics activity.

China and India are high-priority markets due to population size, rising transplant capacity, and increasing genomics investment, with a growing need for ancestry-relevant HLA reference data. Japan and South Korea are advanced adopters of precision diagnostics, automation, and high-quality laboratory workflows, supported by sophisticated healthcare systems and research ecosystems. Australia supports regional leadership through transplant coordination, immunogenetics expertise, national quality frameworks, and high laboratory standards.

Actionable Recommendations for HLA Typing Industry Leaders

Industry leaders should prioritize high-resolution next-generation sequencing workflows, validated bioinformatics, and end-to-end automation that reduce hands-on time without compromising quality. Laboratories increasingly value platforms that support multiple loci, flexible throughput, robust quality metrics, and clear reporting for transplant teams.

Technology providers should invest in regional allele database development, especially for underrepresented populations, because diverse reference data improves interpretation, donor-recipient matching, and equity in access to precision medicine. Strategic partnerships with donor registries, transplant centers, academic medical centers, national genomics programs, and accredited laboratories can accelerate evidence generation and adoption.

Commercial teams should align messaging with clinical utility, turnaround time, accreditation support, cybersecurity, interoperability, service reliability, and total cost of ownership. AI-enabled features should be positioned as validated decision support with transparent auditability, not as a replacement for expert clinical interpretation.

Research Methodology for HLA Typing Analysis

This executive summary is developed using a secondary-research framework that emphasizes verified clinical, regulatory, and scientific evidence. Sources typically include transplant network publications, histocompatibility society guidance, peer-reviewed immunogenetics literature, donor registry data, regulatory documentation, healthcare infrastructure indicators, pharmacogenomic guidelines, and published laboratory performance studies.

The analysis evaluates technology trends, end-user demand, regional adoption patterns, reimbursement considerations, accreditation requirements, interoperability needs, and competitive positioning. Cross-validation is applied by comparing clinical guidelines, registry trends, product performance claims, regulatory requirements, and published evidence to avoid reliance on a single source.

Qualitative interpretation is structured around market drivers, restraints, opportunities, and risks, with emphasis on practical implications for diagnostics manufacturers, laboratories, transplant centers, research institutions, and healthcare investors. The methodology intentionally avoids market sizing, share estimates, and forecasting to keep the analysis focused on evidence-backed strategic insight.

Conclusion: HLA Typing as a Precision Medicine Enabler

HLA typing is moving from a specialized transplant test toward a broader immunogenetics platform that supports precision medicine, donor matching, pharmacogenomics, disease research, vaccine development, and advanced therapy workflows. The strongest opportunities are linked to next-generation sequencing adoption, automated interpretation, AI-assisted decision support, interoperability, and population-specific reference data.

Industry leaders that combine scientific credibility with operational excellence will be best positioned as healthcare systems expand transplant, immunology, oncology, and genomics services worldwide. Accurate typing, rapid turnaround, validated informatics, secure data exchange, regulatory alignment, and strong laboratory support will remain central to durable adoption.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Transplant Compatibility Requirements Anchor Recurring Clinical Demand
4.3.1.2. NGS and Long-Read Sequencing Raise Resolution and Speed Expectations
4.3.1.3. Donor Registry Expansion and Diversity Needs Increase Testing Volume
4.3.1.4. Precision Medicine Broadens HLA Typing Beyond Transplantation
4.3.2. Key Restraints
4.3.2.1. Reimbursement and Budget Constraints Limit Premium Workflow Adoption
4.3.2.2. Validation Burden and Skilled Labor Shortages Slow Workflow Conversion
4.3.3. Key Opportunities
4.3.3.1. Commercialize Rapid Long-Read Typing for Urgent Transplant Workflows
4.3.3.2. Build AI-Enabled Interpretation and Quality Management Platforms
4.3.3.3. Expand IVDR-Ready and Emerging-Market Access Models
4.3.4. Key Challenges
4.3.4.1. Navigate Regulatory Fragmentation Without Slowing Innovation
4.3.4.2. Scale Expert Interpretation Despite Histocompatibility Workforce Shortages
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. HLA Typing Market, by Offering
7.1. Introduction
7.2. Instruments
7.2.1. Molecular Platforms
7.2.1.1. PCR Systems
7.2.1.2. Sequencing Systems
7.2.1.3. Hybridization Readers
7.2.1.4. Microarray Scanners
7.2.1.5. Sample Preparation Automation
7.2.2. Cell-based & Serology Platforms
7.2.2.1. Complement-dependent Cytotoxicity Systems
7.2.2.2. Flow cytometry Systems
7.2.2.3. Immunoassay Readers
7.2.3. Workflow Automation
7.2.3.1. Liquid Handlers
7.2.3.2. Extraction Systems
7.2.3.3. Thermal Cyclers
7.2.3.4. Plate Washers
7.2.3.5. Barcode & Tracking Systems
7.3. Reagents & Consumables
7.3.1. PCR Kits
7.3.2. Sequencing Consumables
7.3.3. Hybridization Consumables
7.3.4. Serology Reagents
7.3.5. General laboratory Consumables
7.4. Software & Informatics
7.4.1. HLA Analysis Software
7.4.2. Genotype Interpretation Software
7.4.3. Laboratory Information Management Software
7.5. Services
7.5.1. HLA Typing Testing Services
7.5.2. Data Analysis Services
7.5.3. Laboratory Support Services
8. HLA Typing Market, by Technology
8.1. Introduction
8.2. Molecular Assay Technologies
8.2.1. Sequence-Specific Oligonucleotide Typing
8.2.2. Sequence-Specific Primer Typing
8.2.3. Sequence-Based Typing
8.2.4. Next-Generation Sequencing Typing
8.3. Non-Molecular Assay Technologies
8.3.1. Serological Typing
8.3.2. Flow Cytometry Typing
9. HLA Typing Market, by Specimen Type
9.1. Introduction
9.2. Blood-derived Specimens
9.3. Oral Specimens
9.4. Cellular Specimens
9.5. Tissue Specimens
10. HLA Typing Market, by Locus Coverage
10.1. Introduction
10.2. Class I Core Loci
10.2.1. HLA-A
10.2.2. HLA-B
10.2.3. HLA-C
10.3. Class II Core Loci
10.3.1. HLA-DRB1
10.3.2. HLA-DQB1
10.3.3. HLA-DPB1
10.3.4. HLA-DQA1
10.3.5. HLA-DPA1
10.4. Extended Loci
10.4.1. HLA-DRB3
10.4.2. HLA-DRB4
10.4.3. HLA-DRB5
10.4.4. HLA-E
10.4.5. HLA-F
10.4.6. HLA-G
11. HLA Typing Market, by Application
11.1. Introduction
11.2. Disease Diagnosis
11.2.1. Autoimmune Diseases
11.2.2. Infectious Diseases
11.2.3. Oncology
11.3. Transplantation
11.4. Pharmacogenomics
11.5. Donor Registry Typing
11.6. Personalized Medicine
11.7. Paternity & Forensic Testing
12. HLA Typing Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Blood Banks & Donor Registries
12.4. Diagnostic Laboratories
12.5. Hospitals & Transplant Centers
12.6. Pharmaceutical & Biotechnology Companies
12.7. Contract Research Organizations
13. HLA Typing Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. HLA Typing Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. HLA Typing Market, by Country
15.1. United States
15.2. China
15.3. Germany
15.4. Japan
15.5. India
15.6. United Kingdom
15.7. Canada
15.8. France
15.9. Brazil
15.10. Australia
15.11. Mexico
15.12. Italy
15.13. South Korea
15.14. Russia
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Thermo Fisher Scientific Inc.
17.2. Werfen, S.A.
17.3. CareDx, Inc.
17.4. Illumina, Inc.
17.5. QIAGEN N.V.
17.6. Bio-Rad Laboratories, Inc.
17.7. Labcorp Holdings Inc.
17.8. Quest Diagnostics Incorporated
17.9. DKMS Life Science Lab gGmbH
17.10. HistoGenetics LLC
17.11. BGI Genomics Co., Ltd.
17.12. Genome Diagnostics B.V.
17.13. BAG Diagnostics GmbH
17.14. ARUP Laboratories
17.15. Oxford Nanopore Technologies plc
17.16. Pacific Biosciences of California, Inc.
17.17. MGI Tech Co., Ltd.
17.18. Versiti, Inc.
17.19. TBG Biotechnology Corp.
17.20. inno-train Diagnostik GmbH
17.21. Fujirebio Holdings, Inc.
17.22. CD Genomics Co., Ltd.
17.23. MedGenome Labs Ltd.
17.24. Biofortuna Limited
17.25. Becton, Dickinson and Company
17.26. Bionobis SAS
17.27. Scisco Genetics Inc.
17.28. GenoCode Limited
17.29. Abbott Laboratories
17.30. Cellecta, Inc.
17.31. DiaSorin S.p.A.
17.32. Novocraft Technologies Sdn Bhd
17.33. TIB Molbiol Syntheselabor GmbH
List of Figures
FIGURE 1. GLOBAL HLA TYPING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HLA TYPING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL HLA TYPING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL HLA TYPING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL HLA TYPING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL HLA TYPING MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL HLA TYPING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HLA TYPING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL HLA TYPING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HLA TYPING MARKET SIZE, BY SPECIMEN TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL HLA TYPING MARKET SIZE, BY SPECIMEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HLA TYPING MARKET SIZE, BY LOCUS COVERAGE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL HLA TYPING MARKET SIZE, BY LOCUS COVERAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL HLA TYPING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL HLA TYPING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL HLA TYPING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL HLA TYPING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL HLA TYPING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL HLA TYPING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL HLA TYPING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL HLA TYPING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL HLA TYPING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL HLA TYPING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL HLA TYPING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL HLA TYPING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL HLA TYPING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL HLA TYPING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL HLA TYPING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL MOLECULAR PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL MOLECULAR PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL MOLECULAR PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PCR SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PCR SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PCR SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SEQUENCING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SEQUENCING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SEQUENCING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL HYBRIDIZATION READERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL HYBRIDIZATION READERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL HYBRIDIZATION READERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL MICROARRAY SCANNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SAMPLE PREPARATION AUTOMATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SAMPLE PREPARATION AUTOMATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SAMPLE PREPARATION AUTOMATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CELL-BASED & SEROLOGY PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CELL-BASED & SEROLOGY PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CELL-BASED & SEROLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL COMPLEMENT-DEPENDENT CYTOTOXICITY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL COMPLEMENT-DEPENDENT CYTOTOXICITY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL COMPLEMENT-DEPENDENT CYTOTOXICITY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL FLOW CYTOMETRY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL FLOW CYTOMETRY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL FLOW CYTOMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL IMMUNOASSAY READERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL IMMUNOASSAY READERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL IMMUNOASSAY READERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL WORKFLOW AUTOMATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL WORKFLOW AUTOMATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL WORKFLOW AUTOMATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL LIQUID HANDLERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL LIQUID HANDLERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL LIQUID HANDLERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL EXTRACTION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL EXTRACTION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL EXTRACTION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL THERMAL CYCLERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL THERMAL CYCLERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL THERMAL CYCLERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PLATE WASHERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PLATE WASHERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PLATE WASHERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BARCODE & TRACKING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BARCODE & TRACKING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BARCODE & TRACKING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PCR KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PCR KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PCR KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SEQUENCING CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SEQUENCING CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SEQUENCING CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL HYBRIDIZATION CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HYBRIDIZATION CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HYBRIDIZATION CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL SEROLOGY REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SEROLOGY REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SEROLOGY REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL GENERAL LABORATORY CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL GENERAL LABORATORY CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL GENERAL LABORATORY CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HLA ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HLA ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HLA ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL GENOTYPE INTERPRETATION SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL GENOTYPE INTERPRETATION SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL GENOTYPE INTERPRETATION SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL LABORATORY INFORMATION MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL LABORATORY INFORMATION MANAGEMENT SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL LABORATORY INFORMATION MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL HLA TYPING TESTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL HLA TYPING TESTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL HLA TYPING TESTING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL LABORATORY SUPPORT SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL LABORATORY SUPPORT SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL LABORATORY SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL HLA TYPING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL MOLECULAR ASSAY TECHNOLOGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL MOLECULAR ASSAY TECHNOLOGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL MOLECULAR ASSAY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL SEQUENCE-SPECIFIC OLIGONUCLEOTIDE TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL SEQUENCE-SPECIFIC OLIGONUCLEOTIDE TYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL SEQUENCE-SPECIFIC OLIGONUCLEOTIDE TYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL SEQUENCE-SPECIFIC PRIMER TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL SEQUENCE-SPECIFIC PRIMER TYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL SEQUENCE-SPECIFIC PRIMER TYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL SEQUENCE-BASED TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL SEQUENCE-BASED TYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL SEQUENCE-BASED TYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL NEXT-GENERATION SEQUENCING TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL NEXT-GENERATION SEQUENCING TYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL NEXT-GENERATION SEQUENCING TYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL NON-MOLECULAR ASSAY TECHNOLOGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL NON-MOLECULAR ASSAY TECHNOLOGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL NON-MOLECULAR ASSAY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL SEROLOGICAL TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL SEROLOGICAL TYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL SEROLOGICAL TYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL FLOW CYTOMETRY TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL FLOW CYTOMETRY TYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL FLOW CYTOMETRY TYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL HLA TYPING MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL BLOOD-DERIVED SPECIMENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL BLOOD-DERIVED SPECIMENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL BLOOD-DERIVED SPECIMENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL ORAL SPECIMENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL ORAL SPECIMENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL ORAL SPECIMENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL CELLULAR SPECIMENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL CELLULAR SPECIMENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL CELLULAR SPECIMENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL TISSUE SPECIMENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL TISSUE SPECIMENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL TISSUE SPECIMENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL HLA TYPING MARKET SIZE, BY LOCUS COVERAGE, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL CLASS I CORE LOCI MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL CLASS I CORE LOCI MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL CLASS I CORE LOCI MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL HLA-A MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL HLA-A MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL HLA-A MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL HLA-B MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL HLA-B MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL HLA-B MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL HLA-C MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL HLA-C MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL HLA-C MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL CLASS II CORE LOCI MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL CLASS II CORE LOCI MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL CLASS II CORE LOCI MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL HLA-DRB1 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL HLA-DRB1 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL HLA-DRB1 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL HLA-DQB1 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL HLA-DQB1 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL HLA-DQB1 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL HLA-DPB1 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL HLA-DPB1 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL HLA-DPB1 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL HLA-DQA1 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL HLA-DQA1 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL HLA-DQA1 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL HLA-DPA1 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL HLA-DPA1 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL HLA-DPA1 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL EXTENDED LOCI MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL EXTENDED LOCI MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL EXTENDED LOCI MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL HLA-DRB3 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL HLA-DRB3 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL HLA-DRB3 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL HLA-DRB4 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL HLA-DRB4 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL HLA-DRB4 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL HLA-DRB5 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL HLA-DRB5 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL HLA-DRB5 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL HLA-E MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL HLA-E MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL HLA-E MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL HLA-F MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 182. GLOBAL HLA-F MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL HLA-F MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL HLA-G MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. GLOBAL HLA-G MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL HLA-G MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL HLA TYPING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 189. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 190. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 191. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 192. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 194. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 195. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 196. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 197. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 198. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 199. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 200. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 201. GLOBAL TRANSPLANTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 202. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 203. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 204. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 205. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 206. GLOBAL DONOR REGISTRY TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 207. GLOBAL DONOR REGISTRY TYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 208. GLOBAL DONOR REGISTRY TYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 209. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 210. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 211. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 212. GLOBAL PATERNITY & FORENSIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 213. GLOBAL PATERNITY & FORENSIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 214. GLOBAL PATERNITY & FORENSIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 215. GLOBAL HLA TYPING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 216. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 217. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 218. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 219. GLOBAL BLOOD BANKS & DONOR REGISTRIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 220. GLOBAL BLOOD BANKS & DONOR REGISTRIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 221. GLOBAL BLOOD BANKS & DONOR REGISTRIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 222. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 223. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 224. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 225. GLOBAL HOSPITALS & TRANSPLANT CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 226. GLOBAL HOSPITALS & TRANSPLANT CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 227. GLOBAL HOSPITALS & TRANSPLANT CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 228. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 229. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 231. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 232. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 233. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 234. GLOBAL HLA TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY MOLECULAR PLATFORMS, 2017-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY CELL-BASED & SEROLOGY PLATFORMS, 2017-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY NON-MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY LOCUS COVERAGE, 2017-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY CLASS I CORE LOCI, 2017-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY CLASS II CORE LOCI, 2017-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY EXTENDED LOCI, 2017-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC HLA TYPING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. EUROPE HLA TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 256. EUROPE HLA TYPING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 257. EUROPE HLA TYPING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 258. EUROPE HLA TYPING MARKET SIZE, BY MOLECULAR PLATFORMS, 2017-2032 (USD MILLION)
TABLE 259. EUROPE HLA TYPING MARKET SIZE, BY CELL-BASED & SEROLOGY PLATFORMS, 2017-2032 (USD MILLION)
TABLE 260. EUROPE HLA TYPING MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 261. EUROPE HLA TYPING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 262. EUROPE HLA TYPING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 263. EUROPE HLA TYPING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 264. EUROPE HLA TYPING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 265. EUROPE HLA TYPING MARKET SIZE, BY MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 266. EUROPE HLA TYPING MARKET SIZE, BY NON-MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 267. EUROPE HLA TYPING MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 268. EUROPE HLA TYPING MARKET SIZE, BY LOCUS COVERAGE, 2017-2032 (USD MILLION)
TABLE 269. EUROPE HLA TYPING MARKET SIZE, BY CLASS I CORE LOCI, 2017-2032 (USD MILLION)
TABLE 270. EUROPE HLA TYPING MARKET SIZE, BY CLASS II CORE LOCI, 2017-2032 (USD MILLION)
TABLE 271. EUROPE HLA TYPING MARKET SIZE, BY EXTENDED LOCI, 2017-2032 (USD MILLION)
TABLE 272. EUROPE HLA TYPING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 273. EUROPE HLA TYPING MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 274. EUROPE HLA TYPING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. NORTH AMERICA HLA TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 276. NORTH AMERICA HLA TYPING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 277. NORTH AMERICA HLA TYPING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 278. NORTH AMERICA HLA TYPING MARKET SIZE, BY MOLECULAR PLATFORMS, 2017-2032 (USD MILLION)
TABLE 279. NORTH AMERICA HLA TYPING MARKET SIZE, BY CELL-BASED & SEROLOGY PLATFORMS, 2017-2032 (USD MILLION)
TABLE 280. NORTH AMERICA HLA TYPING MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 281. NORTH AMERICA HLA TYPING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 282. NORTH AMERICA HLA TYPING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 283. NORTH AMERICA HLA TYPING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 284. NORTH AMERICA HLA TYPING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 285. NORTH AMERICA HLA TYPING MARKET SIZE, BY MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 286. NORTH AMERICA HLA TYPING MARKET SIZE, BY NON-MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 287. NORTH AMERICA HLA TYPING MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 288. NORTH AMERICA HLA TYPING MARKET SIZE, BY LOCUS COVERAGE, 2017-2032 (USD MILLION)
TABLE 289. NORTH AMERICA HLA TYPING MARKET SIZE, BY CLASS I CORE LOCI, 2017-2032 (USD MILLION)
TABLE 290. NORTH AMERICA HLA TYPING MARKET SIZE, BY CLASS II CORE LOCI, 2017-2032 (USD MILLION)
TABLE 291. NORTH AMERICA HLA TYPING MARKET SIZE, BY EXTENDED LOCI, 2017-2032 (USD MILLION)
TABLE 292. NORTH AMERICA HLA TYPING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 293. NORTH AMERICA HLA TYPING MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 294. NORTH AMERICA HLA TYPING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 295. LATIN AMERICA HLA TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 296. LATIN AMERICA HLA TYPING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 297. LATIN AMERICA HLA TYPING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 298. LATIN AMERICA HLA TYPING MARKET SIZE, BY MOLECULAR PLATFORMS, 2017-2032 (USD MILLION)
TABLE 299. LATIN AMERICA HLA TYPING MARKET SIZE, BY CELL-BASED & SEROLOGY PLATFORMS, 2017-2032 (USD MILLION)
TABLE 300. LATIN AMERICA HLA TYPING MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 301. LATIN AMERICA HLA TYPING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 302. LATIN AMERICA HLA TYPING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 303. LATIN AMERICA HLA TYPING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 304. LATIN AMERICA HLA TYPING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 305. LATIN AMERICA HLA TYPING MARKET SIZE, BY MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 306. LATIN AMERICA HLA TYPING MARKET SIZE, BY NON-MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 307. LATIN AMERICA HLA TYPING MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 308. LATIN AMERICA HLA TYPING MARKET SIZE, BY LOCUS COVERAGE, 2017-2032 (USD MILLION)
TABLE 309. LATIN AMERICA HLA TYPING MARKET SIZE, BY CLASS I CORE LOCI, 2017-2032 (USD MILLION)
TABLE 310. LATIN AMERICA HLA TYPING MARKET SIZE, BY CLASS II CORE LOCI, 2017-2032 (USD MILLION)
TABLE 311. LATIN AMERICA HLA TYPING MARKET SIZE, BY EXTENDED LOCI, 2017-2032 (USD MILLION)
TABLE 312. LATIN AMERICA HLA TYPING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 313. LATIN AMERICA HLA TYPING MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 314. LATIN AMERICA HLA TYPING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 315. AFRICA HLA TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 316. AFRICA HLA TYPING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 317. AFRICA HLA TYPING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 318. AFRICA HLA TYPING MARKET SIZE, BY MOLECULAR PLATFORMS, 2017-2032 (USD MILLION)
TABLE 319. AFRICA HLA TYPING MARKET SIZE, BY CELL-BASED & SEROLOGY PLATFORMS, 2017-2032 (USD MILLION)
TABLE 320. AFRICA HLA TYPING MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 321. AFRICA HLA TYPING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 322. AFRICA HLA TYPING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 323. AFRICA HLA TYPING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 324. AFRICA HLA TYPING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 325. AFRICA HLA TYPING MARKET SIZE, BY MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 326. AFRICA HLA TYPING MARKET SIZE, BY NON-MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 327. AFRICA HLA TYPING MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 328. AFRICA HLA TYPING MARKET SIZE, BY LOCUS COVERAGE, 2017-2032 (USD MILLION)
TABLE 329. AFRICA HLA TYPING MARKET SIZE, BY CLASS I CORE LOCI, 2017-2032 (USD MILLION)
TABLE 330. AFRICA HLA TYPING MARKET SIZE, BY CLASS II CORE LOCI, 2017-2032 (USD MILLION)
TABLE 331. AFRICA HLA TYPING MARKET SIZE, BY EXTENDED LOCI, 2017-2032 (USD MILLION)
TABLE 332. AFRICA HLA TYPING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 333. AFRICA HLA TYPING MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 334. AFRICA HLA TYPING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. MIDDLE EAST HLA TYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 336. MIDDLE EAST HLA TYPING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 337. MIDDLE EAST HLA TYPING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 338. MIDDLE EAST HLA TYPING MARKET SIZE, BY MOLECULAR PLATFORMS, 2017-2032 (USD MILLION)
TABLE 339. MIDDLE EAST HLA TYPING MARKET SIZE, BY CELL-BASED & SEROLOGY PLATFORMS, 2017-2032 (USD MILLION)
TABLE 340. MIDDLE EAST HLA TYPING MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 341. MIDDLE EAST HLA TYPING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 342. MIDDLE EAST HLA TYPING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 343. MIDDLE EAST HLA TYPING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 344. MIDDLE EAST HLA TYPING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 345. MIDDLE EAST HLA TYPING MARKET SIZE, BY MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 346. MIDDLE EAST HLA TYPING MARKET SIZE, BY NON-MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 347. MIDDLE EAST HLA TYPING MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 348. MIDDLE EAST HLA TYPING MARKET SIZE, BY LOCUS COVERAGE, 2017-2032 (USD MILLION)
TABLE 349. MIDDLE EAST HLA TYPING MARKET SIZE, BY CLASS I CORE LOCI, 2017-2032 (USD MILLION)
TABLE 350. MIDDLE EAST HLA TYPING MARKET SIZE, BY CLASS II CORE LOCI, 2017-2032 (USD MILLION)
TABLE 351. MIDDLE EAST HLA TYPING MARKET SIZE, BY EXTENDED LOCI, 2017-2032 (USD MILLION)
TABLE 352. MIDDLE EAST HLA TYPING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 353. MIDDLE EAST HLA TYPING MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 354. MIDDLE EAST HLA TYPING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 355. GLOBAL HLA TYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 356. NATO HLA TYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 357. NATO HLA TYPING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 358. NATO HLA TYPING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 359. NATO HLA TYPING MARKET SIZE, BY MOLECULAR PLATFORMS, 2017-2032 (USD MILLION)
TABLE 360. NATO HLA TYPING MARKET SIZE, BY CELL-BASED & SEROLOGY PLATFORMS, 2017-2032 (USD MILLION)
TABLE 361. NATO HLA TYPING MARKET SIZE, BY WORKFLOW AUTOMATION, 2017-2032 (USD MILLION)
TABLE 362. NATO HLA TYPING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 363. NATO HLA TYPING MARKET SIZE, BY SOFTWARE & INFORMATICS, 2017-2032 (USD MILLION)
TABLE 364. NATO HLA TYPING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 365. NATO HLA TYPING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 366. NATO HLA TYPING MARKET SIZE, BY MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 367. NATO HLA TYPING MARKET SIZE, BY NON-MOLECULAR ASSAY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 368. NATO HLA TYPING MARKET SIZE, BY SPECIMEN TYPE, 2017-2032 (USD MILLION)
TABLE 369. NATO HLA TYPING MARKET SIZE, BY LOCUS COVERAGE, 2017-2032 (USD MILLION)
TABLE 370. NATO HLA TYPING MARKET SIZE, BY CLASS I CORE LOCI, 2017-2032 (USD MILLION)
TABLE 371. NATO HLA TYPING MARKET SIZE, BY CLASS II CORE LOCI, 2017-2032 (USD MILLION)
TABLE 372. NATO HLA TYPING MARKET SIZE, BY EXTENDED LOCI, 2017-2032 (USD MILLION)
TABLE 373. NATO HLA TYPING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 374. NATO HLA TYPING MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 375. NATO HLA TYPING MARKET SIZE, BY END

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Werfen, S.A.
  • CareDx, Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • Labcorp Holdings Inc.
  • Quest Diagnostics Incorporated
  • DKMS Life Science Lab gGmbH
  • HistoGenetics LLC
  • BGI Genomics Co., Ltd.
  • Genome Diagnostics B.V.
  • BAG Diagnostics GmbH
  • ARUP Laboratories
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • MGI Tech Co., Ltd.
  • Versiti, Inc.
  • TBG Biotechnology Corp.
  • inno-train Diagnostik GmbH
  • Fujirebio Holdings, Inc.
  • CD Genomics Co., Ltd.
  • MedGenome Labs Ltd.
  • Biofortuna Limited
  • Becton, Dickinson and Company
  • Bionobis SAS
  • Scisco Genetics Inc.
  • GenoCode Limited
  • Abbott Laboratories
  • Cellecta, Inc.
  • DiaSorin S.p.A.
  • Novocraft Technologies Sdn Bhd
  • TIB Molbiol Syntheselabor GmbH

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.77 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.57 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned33

Related Topics

Related Reports

HLA Typing for Transplant Market - Global Forecast 2026-2032 - Product Image

HLA Typing for Transplant Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
HLA Typing for Transplant - Global Strategic Business Report - Product Image

HLA Typing for Transplant - Global Strategic Business Report

  • Report
  • 317 Pages
  • Global
From
HLA Typing For Transplant - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

HLA Typing For Transplant - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
HLA Typing for Transplant Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Product and Service, Application, End User - Product Image

HLA Typing for Transplant Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Product and Service, Application, End User

  • Report
  • 160 Pages
  • Global
From
HLA Typing Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Technology, Application, End User - Product Image

HLA Typing Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Technology, Application, End User

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.